期刊文献+

离子色谱法测定膦甲酸钠注射液含量及有关物质 被引量:4

Determination of Foscarnet Sodium Injection and Its Related Substance by Ion Chromatography
原文传递
导出
摘要 目的建立离子色谱法测定膦甲酸钠注射液含量和有关物质的测定方法。方法色谱柱为Dionex Ionpac AG18(4 mm×50 mm,13μm)+AS18(4 mm×250 mm,7.5μm),以在线EG发生罐产生KOH作为流动相,梯度洗脱,流速1 mL·min-1,电导检测,柱温30℃。结果膦甲酸钠线性范围2~100μg.mL-1,相关系数r=0.999 8,检出限0.3μg·mL-1,杂质亚磷酸根和磷酸根线性范围0.05~2μg·mL-1,相关系数分别为r=0.999 9和r=0.999 8。膦甲酸钠日内精密度RSD为0.35%(n=5),日间精密度0.41%(n=5)。平均加样回收率101%。结论本方法快速、灵敏,专属性强,适用于膦甲酸钠注射液含量及有关物质亚磷酸根和磷酸根的测定。 OBJECTIVE To establish a gradient ion chromatography method to determine the content of foscarnet sodium injection and its related substances. METHODS The separation was performed on an Ionpae AG18 (4 mm × 50 ram, 13 μm) + ASia column (4. 0 mm × 250 mm ,7. 5 μm) using potassium hydroxide produced by eluent generator (EG) as the mobile phase at a flow rate of 1 mL · min^-1 Suppressed conductivity detection was adtopted. The column temperature was maintained at 30 ℃. RESULTS The calibration curve of foscarnet sodium was linear between 2 - 100 μg · mL^-1 r = 0. 999 8 ) , and the calibration curves of the related substances were linear between 0. 05 - 2 μg · mL^-1 ( r = 0. 999 9 and r = 0. 999 8 ). The intra-day and inter-day RSDs of foscarnet sodium were 0. 35% ( n = 5 ) and 0. 41% ( n = 5 ) , respectively. The average recovery was 101%. CONCLUSION The method is specific, sensitive and can be applied to determine the content and impurities of foscarent sodium injection.
出处 《中国药学杂志》 CAS CSCD 北大核心 2012年第20期1658-1660,共3页 Chinese Pharmaceutical Journal
关键词 离子色谱法 膦甲酸钠注射液 含量 亚磷酸根 磷酸根 ion chromatography foscarnet sodium determination phosphite phosphate
  • 相关文献

参考文献7

  • 1MAIKO A, KAZUHIRO I, SATOSHI Y, et al. Use of foscarnet for cytom egalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor [J]. Int J Hematol, 2010, 92(2):351-359.
  • 2GIUSEPPE G, ANTONELLA S, FAUSTO B, et al. Quantitative systemic and local evaluation of the antiviral effect ganciclovir and foscarnet induction treatment on human cytomegalovirus gastrointestinal disease of patients with AIDS [J]. Antiviral Research, 1997,34(1):39-50.
  • 3LAURENCE G, DOMINIQUE S. Pharmacology and clinical use of foscarnet [J] . Int J Anitmicrobl Agents, 1995, 5(4): 209-217.
  • 4USP(34) [S]. 2011:2913.
  • 5National drug standards(国家药品标准)[S].WSl-(X-178)-2004Z.
  • 6苏玉永,魏柳珍.高效液相色谱法测定膦甲酸钠氯化钠注射液中膦甲酸钠的含量[J].中国医院药学杂志,2006,26(10):1244-1245. 被引量:4
  • 7YU Y, LE H W,HU X N, et al. Determination of the antiviral drug trisodium phosphonoformate and its preparations [J]. 重庆医科大学学报,1999,24(3):242-244.

二级参考文献4

共引文献3

同被引文献31

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部